INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 07, 2011 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | -- | 8,812 |
Sep 01, 2009 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | $8.50 | 76,956 |
Sep 01, 2009 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 10,000 | $23.49 | 66,956 |
Sep 01, 2009 |
VP Regul Devel & Med Safety
|
VP Regul Devel & Med Safety | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,000 | -- | -- |
Jan 05, 2005 |
VP, Regulatory Development
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- | 10,000 |
Sep 16, 2008 |
VP, Regul Devel & Med Safety
|
VP, Regul Devel & Med Safety | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 10,361 | $21.16 | 83,995 |
Aug 20, 2008 |
VP, Regul Devel & Med Safety
|
VP, Regul Devel & Med Safety | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 10,582 | $21.40 | 24,102 |
Dec 15, 2004 |
VP, Regulatory Development
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,188 | -- | 11,188 |
Nov 27, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Bona fide gift | 11,500 | -- | 11,500 |
Nov 27, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Bona fide gift | 11,500 | -- | 17,447 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.